[ Price : $8.95]
FDA approves a Kite Oncology labeling update for CAR-T therapy Yescarta (axicabtagene ciloleucel), removing a previous limitation ...[ Price : $8.95]
FDA pledges to move quickly against companies that mass-market illegal copycat drugs by portraying them as equivalent to agency-ap...[ Price : $8.95]
FDA grants Sonorous Neurovascular a breakthrough device designation for its BosSTENT, a cerebral venous stent designed to treat de...[ Price : $8.95]
A new poll finds public confidence in FDA and Centers for Disease Control and Prevention remains low following recent changes to t...[ Price : $8.95]
FDA cites Ipca Laboratories over multiple manufacturing and quality deficiencies following an inspection of the companys active ph...[ Price : $8.95]
A new spending package enacted this week includes two long-sought policy changes for FDA clarifying the scope of orphan drug excl...[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at the U.S. Specialty Formulations outsourcing facility i...[ Price : $8.95]
FDA publishes for public comment an International Council for Harmonization draft guideline on patient preference studies involvin...